Key facts
- This page summarizes Rottinghaus Scott T.'s Form 4 filing for ENANTA PHARMACEUTICALS INC (ENTA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2026, 09:00.
Rottinghaus Scott T. - 08 Aug 2026 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- ENTA
- Reported as of
- 08 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Aug 2026, 09:00:42 UTC
- Prior SEC filing
- 13 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Kowalsky as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rottinghaus Scott T. filed Form 4 for ENANTA PHARMACEUTICALS INC (ENTA) on 10 Aug 2026.
Change
- Previous filing in this sequence was filed on 13 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001942407
Primary reporting owner
Rottinghaus Scott T.
- Relationship
- Chief Medical Officer
- Address
- C/O ENANTA PHARMACEUTICALS, INC., 4 KINGSBURY AVENUE, WATERTOWN
- Signature
- /s/ Matthew Kowalsky as attorney-in-fact
- Signature date
- 10 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENTA
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,467
- Change %
- -5.8%
- Price
- $13.34*
- Shares after
- 23,787
- Date
- 08 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.